ARTICLE | Clinical News
Cavatak: Interim Phase II data
January 7, 2013 8:00 AM UTC
Interim data from 13 evaluable patients with stage IIIc/IV malignant melanoma in the first stage of a 2-stage, open-label, U.S. Phase II trial showed that 10 intratumoral injections of Cavatak produce...